HomeTravelConfidence in cruise and travel sector 'appears very strong,' says Reflexivity CEO...

Confidence in cruise and travel sector ‘appears very strong,’ says Reflexivity CEO Jan Szilagyi

August 6, 2026

Jan Szilagyi, Reflexivity CEO and co-founder, joins ‘Power Lunch’ to discuss if there’s smooth sailing or choppy waters ahead for the cruise and travel industries.

03:04

Thu, Aug 6 20263:32 PM EDT

Source

Cowboys bounce back from club’s ‘darkest day’ to claim crucial win over Titans

American Airlines will stop upgrading elite flyers to business from coach on long domestic flights

admin https://australianbusinessreview.com.au

Most Popular

Confidence in cruise and travel sector ‘appears very strong,’ says Reflexivity CEO Jan Szilagyi

Major US vacation destination could get more expensive as officials eye new fees

Stunned couple unearths 150-pound mystery hidden beneath their backyard for decades

Popular beach town rejects noise, trash and traffic as it weighs stricter vacation rental rules

Most Popular

Coway Vina Installs 164 Water Purifiers at Prince Hotel Da Nang, Accelerating Vietnam Hospitality B2B Expansion

Major US vacation destination could get more expensive as officials eye new fees

Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight...

Kagiso Rabada ruled out as South Africa suffer seismic blow on eve of Australia Test series

Recent Comments

EDITOR PICKS

Coway Vina Installs 164 Water Purifiers at Prince Hotel Da Nang, Accelerating Vietnam Hospitality B2B Expansion

Major US vacation destination could get more expensive as officials eye new fees

Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight...

POPULAR POSTS

Coway Vina Installs 164 Water Purifiers at Prince Hotel Da Nang, Accelerating Vietnam Hospitality B2B Expansion

Major US vacation destination could get more expensive as officials eye new fees

Ascletis Announces First Participant Dosed in a Global Phase III Clinical Program of Once-Daily Oral Small Molecule GLP-1 Receptor Agonist ASC30 for Chronic Weight...

POPULAR CATEGORY

ABOUT US

FOLLOW US